The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation

Biomaterials

Volumn 31, Issue 6, 2010, Pages 1191-1198

  Kawasaki, Toshiki ^a   Niki, Yasuo ^a   Miyamoto, Takeshi ^a   Horiuchi, Keisuke ^a   Matsumoto, Morio ^a   Aizawa, Mamoru ^b   Toyama, Yoshiaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b MEIJI UNIVERSITY   (Japan)

Author keywords

BMP (bone morphogenetic protein); Bone formation; HGF (hepatocyte growth factor); Osteoblast differentiation; Tissue engineering

Indexed keywords

BMP (BONE MORPHOGENETIC PROTEIN); BONE FORMATION; BONE MORPHOGENETIC PROTEINS; BONY DEFECTS; C2C12 MYOBLASTS; CELLULAR PROLIFERATIONS; CLINICAL SETTINGS; ECTOPIC BONES; GELATIN SPONGE; HEPATOCYTE GROWTH FACTOR; HGF TREATMENT; IN-VITRO; MESENCHYMAL STEM CELL; MOUSE EMBRYONIC FIBROBLASTS; MOUSE MODELS; OSTEOBLAST DIFFERENTIATION; OSTEOCALCIN; OSTEOGENESIS; OSTEOGENIC; UP-REGULATION;

BIOACTIVITY; CELL CULTURE; CELL PROLIFERATION; MODULATORS; PEPTIDES; TIME MEASUREMENT; TISSUE ENGINEERING;

BONE;

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALKALINE PHOSPHATASE; GELATIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCALCIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST CULTURE; HISTOLOGY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; MYOBLAST; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; TISSUE ENGINEERING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; DRUG SYNERGISM; HEPATOCYTE GROWTH FACTOR; MICE; MYOBLASTS; OSTEOBLASTS; OSTEOGENESIS; TIME FACTORS; TISSUE ENGINEERING;

EID: 72149116701     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.10.048     Document Type: Article

References (37)

1. Lieberman J.R., Daluiski A., and Einhorn T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A 6 (2002) 1032-1044
2. Gerhart T.N., Kirker-Head C.A., Kriz M.J., Holtrop M.E., Hennig G.E., Hipp J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 293 (1993) 317-326
3. Bostrom M.P., and Camacho N.P. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 355 Suppl. (1998) S274-S282
4. Morisue H., Matsumoto M., Chiba K., Matsumoto H., Toyama Y., Aizawa M., et al. A novel hydroxyapatite fiber mesh as a carrier for recombinant human bone morphogenetic protein-2 enhances bone union in rat posterolateral fusion model. Spine 31 11 (2006) 1194-1200
5. Johnsson R., Stromqvist B., and Aspenberg P. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 volvo award in clinical studies. Spine 27 23 (2002) 2654-2661
6. Schmidmaier G., Schwabe P., Wildemann B., and Haas N.P. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury 38 Suppl. 4 (2007) S35-S41
7. Nakamura Y., Tensho K., Nakaya H., Nawata M., Okabe T., and Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36 3 (2005) 399-407
8. Singhatanadgit W., Salih V., and Olsen I. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions. J Cell Physiol 209 3 (2006) 912-922
9. Maegawa N., Kawamura K., Hirose M., Yajima H., Takakura Y., and Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 1 4 (2007) 306-313
10. Kubota K., Iseki S., Kuroda S., Oida S., Iimura T., Duarte W.R., et al. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 31 4 (2002) 465-471
11. Peng H., Wright V., Usas A., Gearhart B., Shen H.C., Cummins J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110 6 (2002) 751-759
12. Samee M., Kasugai S., Kondo H., Ohya K., Shimokawa H., and Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 108 1 (2008) 18-31
13. Nakamura T., Nawa K., and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122 3 (1984) 1450-1459
14. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 6248 (1989) 440-443
15. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 5309 (1997) 60-66
16. Matsumoto K., and Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 59 6 (2001) 2023-2038
17. Yoshida S., Matsumoto K., Tomioka D., Bessho K., Itami S., Yoshikawa K., et al. Recombinant hepatocyte growth factor accelerates cutaneous wound healing in a diabetic mouse model. Growth Factors 22 2 (2004) 111-119
18. Yamaguchi T., Sawa Y., Miyamoto Y., Takahashi T., Jau C.C., Ahmet I., et al. Therapeutic angiogenesis induced by injecting hepatocyte growth factor in ischemic canine hearts. Surg Today 35 10 (2005) 855-860
19. Sato T., Hakeda Y., Yamaguchi Y., Mano H., Tezuka K., Matsumoto K., et al. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6). J Cell Physiol 164 1 (1995) 197-204
20. Blanquaert F., Delany A.M., and Canalis E. Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. Endocrinology 140 3 (1999) 1069-1074
21. Zambonin G., Camerino C., Greco G., Patella V., Moretti B., and Grano M. Hydroxyapatite coated with heaptocyte growth factor (HGF) stimulates human osteoblasts in vitro. J Bone Joint Surg Br 82 3 (2000) 457-460
22. Hossain M., Irwin R., Baumann M.J., and McCabe L.R. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials 26 15 (2005) 2595-2602
23. Imai Y., Terai H., Nomura-Furuwatari C., Mizuno S., Matsumoto K., Nakamura T., et al. Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors. J Bone Miner Res 20 10 (2005) 1723-1730
24. Standal T., Abildgaard N., Fagerli U.M., Stordal B., Hjertner O., Borset M., et al. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood 109 7 (2007) 3024-3030
25. Horiuchi K., Miyamoto T., Takaishi H., Hakozaki A., Kosaki N., Miyauchi Y., et al. Cell surface colony-stimulating factor 1 can be cleaved by TNF-alpha converting enzyme or endocytosed in a clathrin-dependent manner. J Immunol 179 10 (2007) 6715-6724
26. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127 6 Pt 1 (1994) 1755-1766
27. Halevy O., and Cantley L.C. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Exp Cell Res 297 1 (2004) 224-234
28. Muroya S., Takagi H., Tajima S., and Asano A. Selective inhibition of a step of myotube formation with wheat germ agglutinin in a murine myoblast cell line, C2C12. Cell Struct Funct 19 4 (1994) 241-252
29. Morgan J.E., and Partridge T.A. Muscle satellite cells. Int J Biochem Cell Biol 35 8 (2003) 1151-1156
30. Tatsumi R., Anderson J.E., Nevoret C.J., Halevy O., and Allen R.E. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 194 1 (1998) 114-128
31. Sheehan S.M., Tatsumi R., Temm-Grove C.J., and Allen R.E. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 23 2 (2000) 239-245
32. Gal-Levi R., Leshem Y., Aoki S., Nakamura T., and Halevy O. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochim Biophys Acta 1402 1 (1998) 39-51
33. Ohmichi H., Matsumoto K., and Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration. Am J Physiol 270 6 Pt 1 (1996) L1031-L1039
34. Kosai K., Matsumoto K., Nagata S., Tsujimoto Y., and Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244 3 (1998) 683-690
35. Kretzschmar M., Doody J., and Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389 6651 (1997) 618-622
36. Schindeler A., and Little D.G. Ras-MAPK signaling in osteogenic differentiation: friend or foe?. J Bone Miner Res 21 9 (2006) 1331-1338
37. Sapkota G., Alarcon C., Spagnoli F.M., Brivanlou A.H., and Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25 3 (2007) 441-454